Tianli Zhang, Mengmeng Liu, Qing Liu, & Gary Guishan Xiao. (2022). Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway. Frontiers Media S.A..
Chicago Style (17th ed.) CitationTianli Zhang, Mengmeng Liu, Qing Liu, and Gary Guishan Xiao. Wogonin Increases Gemcitabine Sensitivity in Pancreatic Cancer by Inhibiting Akt Pathway. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationTianli Zhang, et al. Wogonin Increases Gemcitabine Sensitivity in Pancreatic Cancer by Inhibiting Akt Pathway. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.